Cargando…

Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages

BACKGROUND/AIMS: Epigallocatechin-3-gallate (EGCG), the primary catechin in green tea, has anti-inflammatory and anti-oxidative properties. The aim of the current study was to characterize the impact of EGCG on lipopolysaccharide (LPS)-induced innate signaling in bone marrow-derived macrophages (BMM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joo, So-Young, Song, Young-A, Park, Young-Lan, Myung, Eun, Chung, Cho-Yun, Park, Kang-Jin, Cho, Sung-Bum, Lee, Wan-Sik, Kim, Hyun-Soo, Rew, Jong-Sun, Kim, Nack-Sung, Joo, Young-Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343156/ https://www.ncbi.nlm.nih.gov/pubmed/22570747 http://dx.doi.org/10.5009/gnl.2012.6.2.188

Ejemplares similares

Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis
por: Lee, Hye Eun, et al.
Publicado: (2019)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Theaflavin Inhibits LPS-Induced IL-6, MCP-1, and ICAM-1 Expression in Bone Marrow-Derived Macrophages Through the Blockade of NF-κB and MAPK Signaling Pathways
por: Kim, Seewan, et al.
Publicado: (2011)

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2016)

Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment
por: Joo, Hyung Joon, et al.
Publicado: (2018)

(-)-Epigallocatechin-3-Gallate Protects against NO-Induced Ototoxicity through the Regulation of Caspase- 1, Caspase-3, and NF-κB Activation
por: Kim, Su-Jin, et al.
Publicado: (2012)

Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
por: Park, Sunghoon, et al.
Publicado: (2014)

Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells
por: Lee, Myung-Yul, et al.
Publicado: (2013)

Successful side-viewing endoscopic hemoclipping for Dieulafoy-like lesion at the brim of a periampullary diverticulum
por: Lee, Wan Sik, et al.
Publicado: (2010)

Effect of Epigallocatechin-3-Gallate on PMA-Induced MUC5B Expression in Human Airway Epithelial Cells
por: Song, Eun Jung, et al.
Publicado: (2013)

Surgical Correction Is Ineffective for Improvement of Dyssynergic Defecation in Patients With Rectal Prolapse
por: Park, Seon-Young, et al.
Publicado: (2013)

Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer
por: Park, Young-Lan, et al.
Publicado: (2016)

Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice
por: Seong, Kyung-Joo, et al.
Publicado: (2016)

Epigallocatechin-3-gallate suppresses the lipid deposition through the apoptosis during differentiation in bovine bone marrow mesenchymal stem cells
por: Jeong, Jin Young, et al.
Publicado: (2015)

Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
por: Park, Seungil, et al.
Publicado: (2022)

Risk Factors for Food Residue after Distal Gastrectomy and a New Effective Preparation for Endoscopy: The Water-Intake Method
por: Cho, Sung-Bum, et al.
Publicado: (2009)

Aggravation of Dysphagia Aortica After Wearing the Abdominal Binder
por: Park, Seon-Young, et al.
Publicado: (2010)

Antioxidant and Cytoprotective Effects of (−)-Epigallocatechin-3-(3″-O-methyl) Gallate
por: Kim, Eunji, et al.
Publicado: (2019)

Reflux Episode Reaching the Proximal Esophagus Are Associated with Chronic Cough
por: Lee, Jeong-Hyun, et al.
Publicado: (2012)

Epigallocatechin Gallate Protects against Hypoxia-Induced Inflammation in Microglia via NF-κB Suppression and Nrf-2/HO-1 Activation
por: Kim, So-Ra, et al.
Publicado: (2022)

Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers
por: Kim, Tae-Eun, et al.
Publicado: (2017)

Coexistence of Solitary Rectal Ulcer Syndrome and Ulcerative Colitis: A Case Report and Literature Review
por: Park, Hyun Bum, et al.
Publicado: (2014)

Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells
por: Eom, Dae-Woon, et al.
Publicado: (2015)

Radioprotective Effect of Epigallocatechin-3-Gallate on Salivary Gland Dysfunction After Radioiodine Ablation in a Murine Model
por: Choi, Jeong-Seok, et al.
Publicado: (2016)

Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
por: Han, Sang Yun, et al.
Publicado: (2018)

Inhibitory effects of epigallocatechin gallate and its glucoside on the human intestinal maltase inhibition
por: Nguyen, Thi Thanh Hanh, et al.
Publicado: (2012)

Parathyroid Cyst Presenting as Acute Pancreatitis: Report of a Case
por: Kim, Mi-Young, et al.
Publicado: (2013)

Comparison of Endoscopic Variceal Ligation and Endoscopic Variceal Obliteration in Patients with GOV1 Bleeding
por: Hong, Hyoung Ju, et al.
Publicado: (2013)

Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis
por: Song, Young-A, et al.
Publicado: (2011)

Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
por: Cheong, Yucheol, et al.
Publicado: (2021)

Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?
por: Kim, Ka Rham, et al.
Publicado: (2015)

(−)-Epigallocatechin-3-gallate induces secretion of anorexigenic gut hormones
por: Song, Won-Young, et al.
Publicado: (2015)

Epigallocatechin-3-gallate Suppresses Galactose-α1,4-galactose-β1,4-glucose Ceramide Expression in TNF-α Stimulated Human Intestinal Epithelial Cells Through Inhibition of MAPKs and NF-κB
por: Moon, Dong-Oh, et al.
Publicado: (2005)

Inhibitory Effects of Epigallocatechin-3-Gallate on Microsomal Cyclooxygenase-1 Activity in Platelets
por: Lee, Dong-Ha, et al.
Publicado: (2013)

Epigallocatechin-3-gallate protects against hepatic ischaemia–reperfusion injury by reducing oxidative stress and apoptotic cell death
por: Tak, Eunyoung, et al.
Publicado: (2016)

Epigallocatechin-3-Gallate Reduces Visceral Adiposity Partly through the Regulation of Beclin1-Dependent Autophagy in White Adipose Tissues
por: Choi, Cheoljun, et al.
Publicado: (2020)

The Green Tea Component (-)-Epigallocatechin-3-Gallate Sensitizes Primary Endothelial Cells to Arsenite-Induced Apoptosis by Decreasing c-Jun N-Terminal Kinase-Mediated Catalase Activity
por: Kim, Jee-Youn, et al.
Publicado: (2015)

In Vitro Antifungal Activity of Epigallocatechin 3-O-Gallate against Clinical Isolates of Dermatophytes
por: Park, Bong Joo, et al.
Publicado: (2011)

The Role of Vascular Endothelial Growth Factor (VEGF) and p53 Status for Angiogenesis in Gastric Cancer
por: Joo, Young Eun, et al.
Publicado: (2002)

Epigallocatechin-3-gallate suppresses hemin-aggravated colon carcinogenesis through Nrf2-inhibited mitochondrial reactive oxygen species accumulation
por: Seok, Ju Hyung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_feppvticc3gt1kbn0kn1lsuais